These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 8382242

  • 1. Effects of the blockade of the renin-angiotensin system in cyclosporin-induced hypertension.
    Clozel JP, Fischli W, Ménard J.
    J Hypertens; 1993 Jan; 11(1):75-81. PubMed ID: 8382242
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of blood pressure and angiotensin responses to the renin inhibitor Ro 42-5892 and the angiotensin converting enzyme inhibitor enalapril in essential hypertension.
    van den Meiracker AH, Admiraal PJ, Derkx FH, Kleinbloesem C, Man in 't Veld AJ, van Brummelen P, Mulder P, Schalekamp MA.
    J Hypertens; 1993 Aug; 11(8):831-8. PubMed ID: 8228207
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dual blockade of the renin-angiotensin-aldosterone system with high-dose angiotensin-converting enzyme inhibitor for nephroprotection: an open, controlled, randomized study.
    Tylicki L, Renke M, Rutkowski P, Larczyński W, Aleksandrowicz E, Lysiak-Szydlowska W, Rutkowski B.
    Scand J Urol Nephrol; 2008 Aug; 42(4):381-8. PubMed ID: 19230172
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prevention of renal damage by angiotensin II blockade, accompanied by increased renal hepatocyte growth factor in experimental hypertensive rats.
    Matsumoto K, Morishita R, Moriguchi A, Tomita N, Yo Y, Nishii T, Nakamura T, Higaki J, Ogihara T.
    Hypertension; 1999 Aug; 34(2):279-84. PubMed ID: 10454454
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of cilazapril, a converting enzyme inhibitor, on cardiovascular hypertrophy in the hypertensive patient].
    Sesin J, Tamargo J.
    Medicina (B Aires); 1996 Aug; 56(1):75-84. PubMed ID: 8734937
    [Abstract] [Full Text] [Related]

  • 17. Cardiovascular effects of the new angiotensin-converting-enzyme inhibitor, cilazapril, in anesthetized and conscious dogs.
    Holck M, Fischli W, Hefti F, Gerold M.
    J Cardiovasc Pharmacol; 1986 Aug; 8(1):99-108. PubMed ID: 2419701
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cardiovascular pressor reactivity after chronic converting enzyme inhibition.
    Bernasconi M, Marone C, Beretta-Piccoli C, Lepori G, Shaw S, Weidmann P.
    Am J Hypertens; 1991 Apr; 4(4 Pt 1):348-55. PubMed ID: 1829371
    [Abstract] [Full Text] [Related]

  • 20. Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition.
    Kiowski W, Linder L, Kleinbloesem C, van Brummelen P, Bühler FR.
    Circulation; 1992 Jan; 85(1):1-8. PubMed ID: 1728438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.